Frequency Therapeutics Executives
FREQDelisted Stock | USD 0.52 0.03 5.45% |
Frequency Therapeutics employs about 46 people. The company is managed by 10 executives with a total tenure of roughly 108 years, averaging almost 10.0 years of service per executive, having 4.6 employees per reported executive. Discussion of Frequency Therapeutics' management performance can provide insight into the enterprise performance.
Frequency |
Frequency Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.425) % which means that it has lost $0.425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9993) %, meaning that it created substantial loss on money invested by shareholders. Frequency Therapeutics' management efficiency ratios could be used to measure how well Frequency Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Frequency Therapeutics Workforce Comparison
Frequency Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,396. Frequency Therapeutics holds roughly 46.0 in number of employees claiming about 3% of equities under Health Care industry.
Frequency Therapeutics Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Frequency Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Frequency Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Frequency Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mitrano Richard J over a year ago Sale by Mitrano Richard J of 227 shares of Frequency Therapeutics | ||
Mitrano Richard J over a year ago Sale by Mitrano Richard J of 234 shares of Frequency Therapeutics | ||
Mitrano Richard J over a year ago Sale by Mitrano Richard J of 238 shares of Frequency Therapeutics | ||
Mitrano Richard J over a year ago Sale by Mitrano Richard J of 247 shares of Frequency Therapeutics | ||
Mitrano Richard J over a year ago Sale by Mitrano Richard J of 220 shares of Frequency Therapeutics | ||
Mitrano Richard J over a year ago Sale by Mitrano Richard J of 231 shares of Frequency Therapeutics | ||
Mitrano Richard J over a year ago Sale by Mitrano Richard J of 222 shares of Frequency Therapeutics | ||
Mitrano Richard J over a year ago Sale by Mitrano Richard J of 227 shares of Frequency Therapeutics |
Frequency Therapeutics Notable Stakeholders
A Frequency Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Frequency Therapeutics often face trade-offs trying to please all of them. Frequency Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Frequency Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John LaMattina | Advisor Board | Profile | |
David Lucchino | President, CoFounder | Profile | |
James Abely | Associate Sec | Profile | |
Christopher Loose | CoFounder Officer | Profile | |
Jason Glashow | Sr Affairs | Profile | |
William MD | VP Medicine | Profile | |
Quentin McCubbin | Chief Officer | Profile | |
Wendy Arnold | Chief Officer | Profile | |
Carl LeBel | Chief Officer | Profile | |
Dana MD | Chief Officer | Profile |
About Frequency Therapeutics Management Performance
The success or failure of an entity such as Frequency Therapeutics often depends on how effective the management is. Frequency Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Frequency management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Frequency management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a persons innate regenerative potential to restore function. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Frequency Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.
Frequency Therapeutics Workforce Analysis
Traditionally, organizations such as Frequency Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Frequency Therapeutics within its industry.Frequency Therapeutics Manpower Efficiency
Return on Frequency Therapeutics Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.8M | |
Net Loss Per Executive | 8.2M | |
Working Capital Per Employee | 1.4M | |
Working Capital Per Executive | 6.6M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Frequency Stock
If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |